Cardiovascular Disease
Decreases in BMI, HbA1c with diabetes drugs can lower cardiometabolic disease risks
Decreases in body weight and HbA1c induced by GLP-1 receptor agonists and other diabetes drugs can reduce the risk for cardiometabolic complications for adults newly diagnosed with type 2 diabetes, researchers reported.
Impacts of social determinants on cardio-kidney-metabolic disease vary greatly across US
A county-level assessment of deaths from cardio-kidney-metabolic disease and social determinants of health revealed that particular determinants are more or less important in different U.S. regions, researchers reported in JAMA.
Patients with antibody-associated vasculitis can recover kidney function
An early diagnosis of antibody-associated vasculitis may be important to long-term kidney function, study data show, as even mild forms of kidney involvement can affect prognosis.
Older cancer survivors at elevated risk for cardiovascular disease
Older cancer survivors exhibited increased risk for cardiovascular disease than cancer-free individuals of the same age, according to a secondary analysis of a randomized study.
Breast arterial calcification on mammograms may be marker for future heart disease risk
CHICAGO — The presence of breast arterial calcifications on routine mammograms may signal increased risk for atherosclerotic CVD later in life, according to research presented at the Annual Meeting of The Menopause Society.
Neighborhood socioeconomic status linked with heart failure, death for patients with CKD
Neighborhood socioeconomic status was linked with incident heart failure among patients with chronic kidney disease who had more preserved kidney function, study results showed.
Stress, infertility ‘interwoven’ in PCOS, but treatments may improve odds for pregnancy
Women with polycystic ovary syndrome have a higher likelihood of experiencing infertility and subfertility, which can harm mental health and trigger stress, but not everyone with this disorder will require assisted reproduction to conceive.
Rate of kidney replacement therapy for primary glomerular disease varies by country
Rate of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease varies between European countries and was highest for immunoglobulin A nephropathy and focal segmental glomerulosclerosis, study data show.
Hormone therapy use among menopausal women continues to decline, despite proven safety
CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.
Top in endocrinology: PFAS exposure during pregnancy; once-weekly insulin
Exposure to high amounts of certain per- and polyfluoroalkyl substances during pregnancy may cause long-term increases in weight and fat mass, according to research published in The Journal of Clinical Endocrinology & Metabolism.